IBDEI3GR ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,58258,2)
 ;;=^5002641
 ;;^UTILITY(U,$J,358.3,58259,0)
 ;;=E11.351^^272^2905^21
 ;;^UTILITY(U,$J,358.3,58259,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,58259,1,3,0)
 ;;=3^DM Type 2 w/ Prolif Diab Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,58259,1,4,0)
 ;;=4^E11.351
 ;;^UTILITY(U,$J,358.3,58259,2)
 ;;=^5002640
 ;;^UTILITY(U,$J,358.3,58260,0)
 ;;=E11.349^^272^2905^22
 ;;^UTILITY(U,$J,358.3,58260,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,58260,1,3,0)
 ;;=3^DM Type 2 w/ Severe NonProlif Diab Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,58260,1,4,0)
 ;;=4^E11.349
 ;;^UTILITY(U,$J,358.3,58260,2)
 ;;=^5002639
 ;;^UTILITY(U,$J,358.3,58261,0)
 ;;=E11.341^^272^2905^23
 ;;^UTILITY(U,$J,358.3,58261,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,58261,1,3,0)
 ;;=3^DM Type 2 w/ Severe NonProlif Diab Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,58261,1,4,0)
 ;;=4^E11.341
 ;;^UTILITY(U,$J,358.3,58261,2)
 ;;=^5002638
 ;;^UTILITY(U,$J,358.3,58262,0)
 ;;=E11.339^^272^2905^18
 ;;^UTILITY(U,$J,358.3,58262,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,58262,1,3,0)
 ;;=3^DM Type 2 w/ Moderate NonProlif Diab Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,58262,1,4,0)
 ;;=4^E11.339
 ;;^UTILITY(U,$J,358.3,58262,2)
 ;;=^5002637
 ;;^UTILITY(U,$J,358.3,58263,0)
 ;;=E11.331^^272^2905^19
 ;;^UTILITY(U,$J,358.3,58263,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,58263,1,3,0)
 ;;=3^DM Type 2 w/ Moderate NonProlif Diab Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,58263,1,4,0)
 ;;=4^E11.331
 ;;^UTILITY(U,$J,358.3,58263,2)
 ;;=^5002636
 ;;^UTILITY(U,$J,358.3,58264,0)
 ;;=E11.329^^272^2905^16
 ;;^UTILITY(U,$J,358.3,58264,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,58264,1,3,0)
 ;;=3^DM Type 2 w/ Mild NonProlif Diab Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,58264,1,4,0)
 ;;=4^E11.329
 ;;^UTILITY(U,$J,358.3,58264,2)
 ;;=^5002635
 ;;^UTILITY(U,$J,358.3,58265,0)
 ;;=E11.321^^272^2905^17
 ;;^UTILITY(U,$J,358.3,58265,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,58265,1,3,0)
 ;;=3^DM Type 2 w/ Mild NonProlif Diab Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,58265,1,4,0)
 ;;=4^E11.321
 ;;^UTILITY(U,$J,358.3,58265,2)
 ;;=^5002634
 ;;^UTILITY(U,$J,358.3,58266,0)
 ;;=E11.319^^272^2905^24
 ;;^UTILITY(U,$J,358.3,58266,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,58266,1,3,0)
 ;;=3^DM Type 2 w/ Unspec Diab Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,58266,1,4,0)
 ;;=4^E11.319
 ;;^UTILITY(U,$J,358.3,58266,2)
 ;;=^5002633
 ;;^UTILITY(U,$J,358.3,58267,0)
 ;;=E11.311^^272^2905^25
 ;;^UTILITY(U,$J,358.3,58267,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,58267,1,3,0)
 ;;=3^DM Type 2 w/ Unspec Diab Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,58267,1,4,0)
 ;;=4^E11.311
 ;;^UTILITY(U,$J,358.3,58267,2)
 ;;=^5002632
 ;;^UTILITY(U,$J,358.3,58268,0)
 ;;=E10.9^^272^2905^13
 ;;^UTILITY(U,$J,358.3,58268,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,58268,1,3,0)
 ;;=3^DM Type 1 w/o Complications
 ;;^UTILITY(U,$J,358.3,58268,1,4,0)
 ;;=4^E10.9
 ;;^UTILITY(U,$J,358.3,58268,2)
 ;;=^5002626
 ;;^UTILITY(U,$J,358.3,58269,0)
 ;;=E10.311^^272^2905^11
 ;;^UTILITY(U,$J,358.3,58269,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,58269,1,3,0)
 ;;=3^DM Type 1 w/ Unspec Diab Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,58269,1,4,0)
 ;;=4^E10.311
 ;;^UTILITY(U,$J,358.3,58269,2)
 ;;=^5002592
 ;;^UTILITY(U,$J,358.3,58270,0)
 ;;=E10.319^^272^2905^12
 ;;^UTILITY(U,$J,358.3,58270,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,58270,1,3,0)
 ;;=3^DM Type 1 w/ Unspec Diab Retinopathy w/o Macular Edema
